Comparing Cardlytics (CDLX) & Alphabet Inc Class A (GOOGL)

Share on StockTwits

Cardlytics (NASDAQ: GOOGL) and Alphabet Inc Class A (NASDAQ:GOOGL) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Profitability

This table compares Cardlytics and Alphabet Inc Class A’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cardlytics N/A N/A N/A
Alphabet Inc Class A 13.16% 18.24% 14.32%

Valuation & Earnings

This table compares Cardlytics and Alphabet Inc Class A’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cardlytics $130.37 million 4.28 -$19.64 million ($8.02) -3.43
Alphabet Inc Class A $110.86 billion 7.40 $12.66 billion $32.05 36.75

Alphabet Inc Class A has higher revenue and earnings than Cardlytics. Cardlytics is trading at a lower price-to-earnings ratio than Alphabet Inc Class A, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

49.6% of Cardlytics shares are owned by institutional investors. Comparatively, 33.6% of Alphabet Inc Class A shares are owned by institutional investors. 13.2% of Alphabet Inc Class A shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for Cardlytics and Alphabet Inc Class A, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardlytics 0 1 5 0 2.83
Alphabet Inc Class A 0 4 30 0 2.88

Cardlytics currently has a consensus price target of $24.40, indicating a potential downside of 11.30%. Alphabet Inc Class A has a consensus price target of $1,324.02, indicating a potential upside of 12.40%. Given Alphabet Inc Class A’s stronger consensus rating and higher possible upside, analysts plainly believe Alphabet Inc Class A is more favorable than Cardlytics.

Summary

Alphabet Inc Class A beats Cardlytics on 11 of the 12 factors compared between the two stocks.

Cardlytics Company Profile

Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Alphabet Inc Class A Company Profile

Alphabet Inc., through its subsidiaries, provides online advertising services in the United States and internationally. The company offers performance and brand advertising services. It operates through Google and Other Bets segments. The Google segment includes principal Internet products, such as Ads, Android, Chrome, Commerce, Google Cloud, Google Maps, Google Play, Hardware, Search, and YouTube, as well as technical infrastructure and newer efforts, including Virtual Reality. This segment also offers digital content, enterprise cloud services, and hardware products, as well as other miscellaneous products and services. The Other Bets segment includes businesses, such as Access, Calico, CapitalG, GV, Nest, Verily, Waymo, and X, as well as fiber Internet and Television services. Alphabet Inc. was founded in 1998 and is headquartered in Mountain View, California.

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.